𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HLA-antigens and the prognosis of multiple sclerosis

✍ Scribed by Sigrid Poser; G. Ritter; H. J. Bauer; H. Grosse-Wilde; E. K. Kuwert; N. E. Raun


Publisher
Springer
Year
1981
Tongue
English
Weight
143 KB
Volume
225
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

✦ Synopsis


The histocompatibility pattern of 160 patients with multiple sclerosis (MS) living in the epidemiological area of Southern Lower Saxony was determined and compared to a control population. The only significant difference was the more frequent occurrence of DW2 in the patient group (44% vs. 21%). Taking a progression index (grade of disability divided by the duration of the disease) as a measure for prognosis no difference could be found between the DW2 positive and the DW2 negative patients. The reason why we could not confirm the worse prognosis for DW2 positive patients found by Jersild et al. (1973) and Raun et al. (1980) remains to be investigated.


πŸ“œ SIMILAR VOLUMES


HLA and prognosis in multiple sclerosis
✍ BjΓΆrn Runmarker; Tommy Martinsson; Jan WahlstrΓΆm; Oluf Andersen πŸ“‚ Article πŸ“… 1994 πŸ› Springer 🌐 English βš– 581 KB
HLA antigens in Italian multiple scleros
✍ L. La Mantia; M. T. Illeni; C. Milanese; A. Salmaggi; M. Eoli; G. Pellegris; A. πŸ“‚ Article πŸ“… 1991 πŸ› Springer Milan 🌐 English βš– 432 KB
HLA antigens and progression of multiple
✍ L. Dejaegher; M. Bruyere; P. Ketelaer; H. Carton πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 375 KB

The HLA-A, -B, -C and -D were determined in 200 multiple sclerosis (MS) patients, 64 of whom underwent a CSF examination. Their frequencies were correlated with the rate of disease progression and with factors thought to influence disease progression, including onset age, type of clinical course and

HLA antigens-linked genetic control in m
✍ G. Lamoureux; P. Duquette; Y. Lapierre; B. Cosgrove; G. Bourret; L. Labrie πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 739 KB

Patients with multiple sclerosis (MS) from the two Montreal MS clinics, were divided into two groups: one group of 61 patients (MS type I) who had no clinical history of susceptibility to recurrent respiratory tract infections and a second group of 58 patients (MS type II) who had persistent suscept